Mitoxantrone plus gemcitabine in pretreated patients with advanced breast cancer.

被引：0
|
作者：
Onyenadum, A [1 ]
Kosmidis, P [1 ]
Aravantinos, G [1 ]
Bafaloukos, D [1 ]
Gogas, H [1 ]
Bacoyiannis, C [1 ]
Razis, E [1 ]
Markopoulos, C [1 ]
Makatsoris, T [1 ]
Kalofonos, HP [1 ]
机构：
[1] Hellen Cooperat Oncol Grp, Athens, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
829
引用
收藏
页码：83S / 83S
页数：1
相关论文
共 50 条
  • [31] A combination of Capecitabine plus Gemcitabine in pretreated patients with metastatic breast cancer: What's the right schedule?
    Nardi, Mario
    Azzarello, Domenico
    Carboni, Rita
    Zavettieri, Maria
    Raffaele, Mario
    Mare, Marzia
    Giannicola, Rocco
    Panuccio, Vincenzo
    Falzea, Antonella
    Del Medico, Pietro
    ANNALS OF ONCOLOGY, 2004, 15 : 54 - 54
  • [32] Gemcitabine and carboplatin in intensively pretreated patients with metastatic breast cancer
    Laessig, D.
    Stemmler, H. J.
    Vehling-Kaiser, U.
    Fasching, P. A.
    Melchert, F.
    Koelbl, H.
    Stauch, M.
    Maubach, P.
    Scharl, A.
    Morack, G.
    Meerpohl, H.
    Weber, B.
    Kalischefski, B.
    Heinemann, V.
    ONCOLOGY, 2007, 73 (5-6) : 407 - 414
  • [33] The use of gemcitabine (G) in heavily pretreated breast cancer patients
    Valerio, M. R.
    Benfante, B.
    Scibilia, C.
    Spinnato, F.
    Cicero, G.
    Scaglione, D.
    Cocchiera, A.
    Amato, C.
    Cipolla, C.
    Graceffa, G.
    Russo, A.
    Fulfaro, F.
    D'Angelo, G.
    ANNALS OF ONCOLOGY, 2005, 16 : 145 - 145
  • [34] Unexpected severe myelotoxicity of gemcitabine in pretreated breast cancer patients
    Locker, GJ
    Wenzel, C
    Schmidinger, M
    Gnant, MFX
    Marosi, C
    Jakesz, R
    Zielinski, CC
    Steger, GG
    ANTI-CANCER DRUGS, 2001, 12 (03) : 209 - 212
  • [35] Gemcitabine plus irinotecan in breast cancer patients pretreated with taxanes and anthracyclines: A multicenter phase II study
    Agelaki, S
    Karyda, E
    Kouroussis, C
    Ardavanis, A
    Kalbakis, K
    Malas, K
    Malamos, N
    Alexopoulos, A
    Tselepatiotis, E
    Georgoulias, V
    ONCOLOGY, 2003, 64 (04) : 477 - 478
  • [36] Safety and efficacy of eribulin in combination with gemcitabine in patients with advanced triple negative breast cancer.
    Michalaki, Vasiliki
    Fragulidis, Georgios
    Kondis, Ioannis
    Karvouni, Eleni
    Dafnios, Nikolaos
    Kotsiou, Antonia
    Vassiliou, Ioannis
    Papadimitriou, Christos
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [37] Gemcitabine plus cisplatin therapy, a safety regimen in advanced bladder cancer.
    Song, J
    Chung, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 452S - 452S
  • [38] Neoadjuvant chemotherpay with gemcitabine plus carboplatin in advanced and unresectable gastric cancer.
    Leoner, C
    Mora, J
    Delgadillo, F
    Gallardo, D
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 373S - 373S
  • [39] ETOPOSIDE PLUS CISPLATIN COMBINATION THERAPY IN PATIENTS WITH ADVANCED BREAST CANCER PRETREATED WITH ANTHRACYCLINES
    Ahn, Byong Hyon
    Chang, Eil Sung
    BREAST, 2013, 22 : S50 - S50
  • [40] Mitoxantrone in the treatment of metastatic breast cancer.
    Bukavin, AS
    EXPERIMENTAL ONCOLOGY, 1996, 18 (03): : 280 - 283
12345